Human Signal peptide, CUB and EGF-like domain-containing protein 3,SCUBE3 ELISA Kit

Contact us for 48 wells and bulk quote

The Human Signal Peptide, CUB and EGF-Like Domain-Containing Protein 3, SCUBE3 ELISA Kit is a highly advanced and sophisticated product designed to accurately measure the levels of SCUBE3 protein in human serum, plasma, and other biological fluids. This kit is based on the enzyme-linked immunosorbent assay (ELISA) technique, which is widely recognized as a reliable and sensitive method for protein quantification.

The SCUBE3 protein is a member of the SCUBE family of proteins, which are involved in various biological processes such as cell adhesion, angiogenesis, and embryonic development. The SCUBE3 protein contains a signal peptide, a CUB domain, and multiple EGF-like domains, which are important for its biological function.

The Human Signal Peptide, CUB and EGF-Like Domain-Containing Protein 3, SCUBE3 ELISA Kit is composed of high-quality reagents and materials that have been rigorously tested for their specificity, sensitivity, and accuracy. The kit includes a microplate coated with a monoclonal antibody specific to SCUBE3 protein, a set of standards, and a detection antibody conjugated to horseradish peroxidase (HRP).

The assay procedure is simple and straightforward, and can be completed within a few hours. The samples are added to the microplate, along with the standards and the detection antibody. After incubation and washing steps, a substrate solution is added, which reacts with the HRP-conjugated detection antibody to produce a colorimetric signal. The intensity of the signal is proportional to the amount of SCUBE3 protein present in the sample.

The Human Signal Peptide, CUB and EGF-Like Domain-Containing Protein 3, SCUBE3 ELISA Kit is a valuable tool for researchers and clinicians who are interested in studying the role of SCUBE3 protein in various physiological and pathological conditions. Its high sensitivity and specificity make it an ideal choice for biomarker discovery, drug development, and clinical diagnostics.